Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Isolated right superior vena cava draining into the left atrium in a child with vein of Galen aneurysmal malformation-case report.

Elmahrouk AF, Helal A, Ismail MF, Hamouda T, Mashali M, Jamjoom AA, Al-Ata JA.

J Cardiothorac Surg. 2018 Jun 13;13(1):66. doi: 10.1186/s13019-018-0758-x.

2.

Smart textile framework: Photochromic and fluorescent cellulosic fabric printed by strontium aluminate pigment.

Khattab TA, Rehan M, Hamouda T.

Carbohydr Polym. 2018 Sep 1;195:143-152. doi: 10.1016/j.carbpol.2018.04.084. Epub 2018 Apr 23.

PMID:
29804962
3.

Transposition of Great Arteries with Left Main Coronary Artery Atresia-Case Report.

Elmahrouk AF, Hamouda T, Ismail MF, Jamjoom A.

Thorac Cardiovasc Surg Rep. 2018 Jan;7(1):e16-e17. doi: 10.1055/s-0038-1637737. Epub 2018 Mar 22.

4.

Staged Surgical Palliation for HLHS in a Girl with Severe Factor X Deficiency.

Elmahrouk AF, Ismail MF, Bugis A, Badawy N, Aboelghar HM, Hamouda T, Jamjoom A.

Thorac Cardiovasc Surg Rep. 2018 Jan;7(1):e12-e15. doi: 10.1055/s-0038-1637743. Epub 2018 Mar 22.

5.

Extracorporeal Membrane Oxygenation in Postcardiotomy Pediatric Patients-15 Years of Experience Outside Europe and North America.

ElMahrouk AF, Ismail MF, Hamouda T, Shaikh R, Mahmoud A, Shihata MS, Alradi O, Jamjoom A.

Thorac Cardiovasc Surg. 2017 Dec 12. doi: 10.1055/s-0037-1608962. [Epub ahead of print] No abstract available.

PMID:
29232733
6.

A novel nanoemulsion vaccine induces mucosal Interleukin-17 responses and confers protection upon Mycobacterium tuberculosis challenge in mice.

Ahmed M, Smith DM, Hamouda T, Rangel-Moreno J, Fattom A, Khader SA.

Vaccine. 2017 Sep 5;35(37):4983-4989. doi: 10.1016/j.vaccine.2017.07.073. Epub 2017 Jul 31.

PMID:
28774560
7.

Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats.

O'Konek JJ, Makidon PE, Landers JJ, Cao Z, Malinczak CA, Pannu J, Sun J, Bitko V, Ciotti S, Hamouda T, Wojcinski ZW, Lukacs NW, Fattom A, Baker JR Jr.

Hum Vaccin Immunother. 2015;11(12):2904-12. doi: 10.1080/21645515.2015.1075680.

8.

Formulation, high throughput in vitro screening and in vivo functional characterization of nanoemulsion-based intranasal vaccine adjuvants.

Wong PT, Leroueil PR, Smith DM, Ciotti S, Bielinska AU, Janczak KW, Mullen CH, Groom JV 2nd, Taylor EM, Passmore C, Makidon PE, O'Konek JJ, Myc A, Hamouda T, Baker JR Jr.

PLoS One. 2015 May 11;10(5):e0126120. doi: 10.1371/journal.pone.0126120. eCollection 2015.

9.

Intranasal immunization with W 80 5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model.

Passmore C, Makidon PE, O'Konek JJ, Zahn JA, Pannu J, Hamouda T, Bitko V, Myc A, Lukacs NW, Fattom A, Baker JR Jr.

Hum Vaccin Immunother. 2014;10(3):615-22. Epub 2013 Dec 10.

10.

Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine.

Das SC, Hatta M, Wilker PR, Myc A, Hamouda T, Neumann G, Baker JR Jr, Kawaoka Y.

Vaccine. 2012 Nov 6;30(48):6871-7. doi: 10.1016/j.vaccine.2012.09.007. Epub 2012 Sep 16.

11.

Management of genital warts in pregnancy.

Hamouda T, Freij MA, Saleh M.

Clin Exp Obstet Gynecol. 2012;39(2):242-4.

PMID:
22905475
12.

Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens.

Stanberry LR, Simon JK, Johnson C, Robinson PL, Morry J, Flack MR, Gracon S, Myc A, Hamouda T, Baker JR Jr.

Vaccine. 2012 Jan 5;30(2):307-16. doi: 10.1016/j.vaccine.2011.10.094. Epub 2011 Nov 8.

PMID:
22079079
13.

Primary ovarian choriocarcinoma presenting with acute abdomen mimicking an ectopic pregnancy.

Freij MA, Saleh H, Hamouda T, Raje G, Saleh M.

Eur J Gynaecol Oncol. 2011;32(4):425-6.

PMID:
21941968
14.

A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease.

Lindell DM, Morris SB, White MP, Kallal LE, Lundy PK, Hamouda T, Baker JR Jr, Lukacs NW.

PLoS One. 2011;6(7):e21823. doi: 10.1371/journal.pone.0021823. Epub 2011 Jul 15.

15.

In vitro antibacterial activity of NB-003 against Propionibacterium acnes.

Pannu J, McCarthy A, Martin A, Hamouda T, Ciotti S, Ma L, Sutcliffe J, Baker JR Jr.

Antimicrob Agents Chemother. 2011 Sep;55(9):4211-7. doi: 10.1128/AAC.00561-11. Epub 2011 Jul 11.

16.

Intranasal immunization of ferrets with commercial trivalent influenza vaccines formulated in a nanoemulsion-based adjuvant.

Hamouda T, Sutcliffe JA, Ciotti S, Baker JR Jr.

Clin Vaccine Immunol. 2011 Jul;18(7):1167-75. doi: 10.1128/CVI.00035-11. Epub 2011 May 4.

17.

Efficacy, immunogenicity and stability of a novel intranasal nanoemulsion-adjuvanted influenza vaccine in a murine model.

Hamouda T, Chepurnov A, Mank N, Knowlton J, Chepurnova T, Myc A, Sutcliffe J, Baker JR.

Hum Vaccin. 2010 Jul;6(7):585-94.

PMID:
20421727
18.

Topical nanoemulsion therapy reduces bacterial wound infection and inflammation after burn injury.

Hemmila MR, Mattar A, Taddonio MA, Arbabi S, Hamouda T, Ward PA, Wang SC, Baker JR Jr.

Surgery. 2010 Sep;148(3):499-509. doi: 10.1016/j.surg.2010.01.001. Epub 2010 Mar 2.

19.

NB-002, a novel nanoemulsion with broad antifungal activity against dermatophytes, other filamentous fungi, and Candida albicans.

Pannu J, McCarthy A, Martin A, Hamouda T, Ciotti S, Fothergill A, Sutcliffe J.

Antimicrob Agents Chemother. 2009 Aug;53(8):3273-9. doi: 10.1128/AAC.00218-09. Epub 2009 May 11.

20.

Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion.

Myc A, Kukowska-Latallo JF, Bielinska AU, Cao P, Myc PP, Janczak K, Sturm TR, Grabinski MS, Landers JJ, Young KS, Chang J, Hamouda T, Olszewski MA, Baker JR Jr.

Vaccine. 2003 Sep 8;21(25-26):3801-14.

PMID:
12922114

Supplemental Content

Loading ...
Support Center